Literature DB >> 24814604

Adverse signaling of scavenger receptor class B1 and PGC1s in alcoholic hepatosteatosis and steatohepatitis and protection by betaine in rat.

Ravi Varatharajalu1, Mamatha Garige1, Leslie C Leckey1, Jaime Arellanes-Robledo1, Karina Reyes-Gordillo1, Ruchi Shah1, M Raj Lakshman2.   

Abstract

Because scavenger receptor class B type 1 is the cholesterol uptake liver receptor, whereas peroxisome proliferator-activated receptor γ coactivator-1β (PGC-1β) and PGC-1α are critical for lipid synthesis and degradation, we investigated the roles of these signaling molecules in the actions of ethanol-polyunsaturated fatty acids and betaine on hepatosteatosis and steatohepatitis. Ethanol-polyunsaturated fatty acid treatment caused the following: i) hepatosteatosis, as evidenced by increased liver cholesterol and triglycerides, lipid score, and decreased serum adiponectin; ii) marked inhibition of scavenger receptor class B type 1 glycosylation, its plasma membrane localization, and its hepatic cholesterol uptake function; and iii) moderate steatohepatitis, as evidenced by histopathological characteristics, increased liver tumor necrosis factor α and IL-6, decreased glutathione, and elevated serum alanine aminotransferase. These actions of ethanol involved up-regulated PGC-1β, sterol regulatory element-binding proteins 1c and 2, acetyl-CoA carboxylase, and HMG-CoA reductase mRNAs/proteins and inactive non-phosphorylated AMP kinase; and down-regulated silence regulator gene 1 and PGC-1α mRNA/proteins and hepatic fatty acid oxidation. Betaine markedly blunted all these actions of ethanol on hepatosteatosis and steatohepatitis. Therefore, we conclude that ethanol-mediated impaired post-translational modification, trafficking, and function of scavenger receptor class B type 1 may account for alcoholic hyperlipidemia. Up-regulation of PGC-1β and lipid synthetic genes and down-regulation of silence regulator gene 1, PGC-1α, adiponectin, and lipid degradation genes account for alcoholic hepatosteatosis. Induction of proinflammatory cytokines and depletion of endogenous antioxidant, glutathione, account for alcoholic steatohepatitis. We suggest betaine as a potential therapeutic agent because it effectively protects against adverse actions of ethanol.
Copyright © 2014 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24814604      PMCID: PMC4076464          DOI: 10.1016/j.ajpath.2014.03.005

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  43 in total

1.  Chronic ethanol induced impairment of hepatic glycosylation machinery in rat is independent of dietary carbohydrate.

Authors:  P Ghosh; M R Lakshman
Journal:  Alcohol Clin Exp Res       Date:  1997-02       Impact factor: 3.455

2.  Chronic ethanol administration impairs the binding and endocytosis of asialo-orosomucoid in isolated hepatocytes.

Authors:  C A Casey; S L Kragskow; M F Sorrell; D J Tuma
Journal:  J Biol Chem       Date:  1987-02-25       Impact factor: 5.157

3.  Identification of scavenger receptor SR-BI as a high density lipoprotein receptor.

Authors:  S Acton; A Rigotti; K T Landschulz; S Xu; H H Hobbs; M Krieger
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728

4.  Dietary betaine promotes generation of hepatic S-adenosylmethionine and protects the liver from ethanol-induced fatty infiltration.

Authors:  A J Barak; H C Beckenhauer; M Junnila; D J Tuma
Journal:  Alcohol Clin Exp Res       Date:  1993-06       Impact factor: 3.455

5.  Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure.

Authors:  L I Gidez; G J Miller; M Burstein; S Slagle; H A Eder
Journal:  J Lipid Res       Date:  1982-11       Impact factor: 5.922

6.  Decreased binding of asialoglycoproteins to hepatocytes from ethanol-fed rats. Consequence of both impaired synthesis and inactivation of the asialoglycoprotein receptor.

Authors:  B L Tworek; D J Tuma; C A Casey
Journal:  J Biol Chem       Date:  1996-02-02       Impact factor: 5.157

7.  Long-term ethanol exposure impairs glycosylation of both N- and O-glycosylated proteins in rat liver.

Authors:  P Ghosh; Q H Liu; M R Lakshman
Journal:  Metabolism       Date:  1995-07       Impact factor: 8.694

8.  Microplate methods for determination of serum cholesterol, high density lipoprotein cholesterol, triglyceride and apolipoproteins.

Authors:  R B Shireman; J Durieux
Journal:  Lipids       Date:  1993-02       Impact factor: 1.880

Review 9.  Molecular genetics of the LDL receptor gene in familial hypercholesterolemia.

Authors:  H H Hobbs; M S Brown; J L Goldstein
Journal:  Hum Mutat       Date:  1992       Impact factor: 4.878

10.  Pathogenesis of alcohol-induced accumulation of protein in the liver.

Authors:  E Baraona; M A Leo; S A Borowsky; C S Lieber
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

View more
  11 in total

1.  Ethanol targets nucleoredoxin/dishevelled interactions and stimulates phosphatidylinositol 4-phosphate production in vivo and in vitro.

Authors:  Jaime Arellanes-Robledo; Karina Reyes-Gordillo; Joseph Ibrahim; Leslie Leckey; Ruchi Shah; M Raj Lakshman
Journal:  Biochem Pharmacol       Date:  2018-08-18       Impact factor: 5.858

2.  Combined intake of blueberry juice and probiotics ameliorate mitochondrial dysfunction by activating SIRT1 in alcoholic fatty liver disease.

Authors:  Houmin Fan; Yanyan Shen; Ya Ren; Qiuju Mou; Tao Lin; Lili Zhu; Tingting Ren
Journal:  Nutr Metab (Lond)       Date:  2021-05-10       Impact factor: 4.169

Review 3.  Glutathione and mitochondria.

Authors:  Vicent Ribas; Carmen García-Ruiz; José C Fernández-Checa
Journal:  Front Pharmacol       Date:  2014-07-01       Impact factor: 5.810

Review 4.  Mitochondrial cholesterol accumulation in alcoholic liver disease: Role of ASMase and endoplasmic reticulum stress.

Authors:  Montserrat Marí; Albert Morales; Anna Colell; Carmen García-Ruiz; Jose C Fernández-Checa
Journal:  Redox Biol       Date:  2014-09-28       Impact factor: 11.799

5.  Mitochondrial GSH replenishment as a potential therapeutic approach for Niemann Pick type C disease.

Authors:  Sandra Torres; Nuria Matías; Anna Baulies; Susana Nuñez; Cristina Alarcon-Vila; Laura Martinez; Natalia Nuño; Anna Fernandez; Joan Caballeria; Thierry Levade; Alba Gonzalez-Franquesa; Pablo Garcia-Rovés; Elisa Balboa; Silvana Zanlungo; Gemma Fabrías; Josefina Casas; Carlos Enrich; Carmen Garcia-Ruiz; José C Fernández-Checa
Journal:  Redox Biol       Date:  2016-11-20       Impact factor: 11.799

6.  Low-ω3 Fatty Acid and Soy Protein Attenuate Alcohol-Induced Fatty Liver and Injury by Regulating the Opposing Lipid Oxidation and Lipogenic Signaling Pathways.

Authors:  Karina Reyes-Gordillo; Ruchi Shah; Ravi Varatharajalu; Mamatha Garige; Leslie C Leckey; M Raj Lakshman
Journal:  Oxid Med Cell Longev       Date:  2016-12-18       Impact factor: 6.543

7.  Betaine attenuates chronic alcohol‑induced fatty liver by broadly regulating hepatic lipid metabolism.

Authors:  Wenjuan Yang; Luming Huang; Jinhang Gao; Shilei Wen; Yang Tai; Meng Chen; Zhiyin Huang; Rui Liu; Chengwei Tang; Jing Li
Journal:  Mol Med Rep       Date:  2017-08-21       Impact factor: 2.952

Review 8.  Role of betaine in liver disease-worth revisiting or has the die been cast?

Authors:  Sandeep Mukherjee
Journal:  World J Gastroenterol       Date:  2020-10-14       Impact factor: 5.742

Review 9.  Regulation of Cytochrome c Oxidase by Natural Compounds Resveratrol, (-)-Epicatechin, and Betaine.

Authors:  Icksoo Lee
Journal:  Cells       Date:  2021-05-29       Impact factor: 6.600

10.  Dietary Betaine Addition Promotes Hepatic Cholesterol Synthesis, Bile Acid Conversion, and Export in Rats.

Authors:  Sisi Li; Shuyi Xu; Yang Zhao; Haichao Wang; Jie Feng
Journal:  Nutrients       Date:  2020-05-13       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.